Can a quick chat in a family planning clinic curb risky drinking and drug use?

NCT ID NCT05910580

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a program called SBIRT (Screening, Brief Intervention, and Referral to Treatment) can help people reduce risky alcohol and drug use. About 400 adults visiting family planning clinics will either get SBIRT or usual care. Researchers will track changes in drinking, drug use, and related health outcomes over three months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Screening, Brief Intervention, and Referral to Treatment (SBIRT)
What this could lead to
If it works, this could provide a practical way to help people reduce risky alcohol and drug use during their reproductive years, improving overall health and well-being.
What could go wrong
This is a relatively early-stage study with 400 participants, and the intervention is behavioral, so results may vary. It may not show a strong effect or be easily adopted in all clinics.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALCOHOL-RELATED DISORDERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Central Massachusetts Health Center

    RECRUITING

    Worcester, Massachusetts, 01609, United States

  • Greater Boston Health Center

    RECRUITING

    Boston, Massachusetts, 02215, United States

  • Metro West Health Center

    RECRUITING

    Marlborough, Massachusetts, 01752, United States

  • Western Massachusetts Health Center

    RECRUITING

    Springfield, Massachusetts, 01107, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.